SciTropin™ is recombinant human growth hormone synthesised in E. coli cells. It is identical to naturally-occurring human growth hormone. SciTropin™ is used for the treatment of short stature due to growth hormone deficiency in children, the chromosomal abnormality Turner syndrome in which females lack one of the two X chromosomes, chronic kidney problems, muscle wasting in AIDS and other conditions and growth hormone deficiency in adults.

The Global Growth Hormone Market is now estimated to be at US$2.5 billion.